• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

制定并验证了一个列线图,用于预测未经手术治疗的老年前列腺癌患者的癌症特异性生存。

Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.

机构信息

Department of Urology, Chongqing Key Laboratory of Children Urogenital Development and Tissue Engineering, Chongqing Key Laboratory of Pediatrics, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing Higher Institution Engineering Research Center of Children's Medical Big Data Intelligent Application, Chongqing, People's Republic of China.

Department of Urology, Affiliated Hospital of Yunnan University (The Second People's Hospital of Yunnan Province, Ophthalmic Hospital of Yunnan Province), Kunming, Yunnan, People's Republic of China.

出版信息

Sci Rep. 2023 Oct 18;13(1):17719. doi: 10.1038/s41598-023-44911-z.

DOI:10.1038/s41598-023-44911-z
PMID:37853026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10584808/
Abstract

Prostate Cancer (PC) is the most common male nonskin tumour in the world, and most diagnosed patients are over 65 years old. The main treatment for PC includes surgical treatment and nonsurgical treatment. Currently, for nonsurgically treated elderly patients, few studies have evaluated their prognostic factors. Our aim was to construct a nomogram that could predict cancer-specific survival (CSS) in nonsurgically treated elderly PC patients to assess their prognosis-related independent risk factors. Patient information was obtained from the Surveillance, Epidemiology and End Results (SEER) database, and our target population was nonsurgically treated PC patients who were over 65 years old. Independent risk factors were determined using both univariate and multivariate Cox regression models. A nomogram was built using a multivariate Cox regression model. The accuracy and discrimination of the prediction model were tested using the consistency index (C-index), the area under the subject operating characteristic curve (AUC), and the calibration curve. Decision curve analysis (DCA) was used to examine the potential clinical value of this model. A total of 87,831 elderly PC patients with nonsurgical treatment in 2010-2018 were included in the study and were randomly assigned to the training set (N = 61,595) and the validation set (N = 26,236). Univariate and multivariate Cox regression model analyses showed that age, race, marital status, TNM stage, chemotherapy, radiotherapy modality, PSA and GS were independent risk factors for predicting CSS in nonsurgically treated elderly PC patients. The C-index of the training set and the validation set was 0.894 (95% CI 0.888-0.900) and 0.897 (95% CI 0.887-0.907), respectively, indicating the good discrimination ability of the nomogram. The AUC and the calibration curves also show good accuracy and discriminability. We developed a new nomogram to predict CSS in elderly PC patients with nonsurgical treatment. The model is internally validated with good accuracy and reliability, as well as potential clinical value, and can be used for clinical aid in decision-making.

摘要

前列腺癌(PC)是世界上最常见的男性非皮肤肿瘤,大多数诊断出的患者年龄超过 65 岁。PC 的主要治疗方法包括手术治疗和非手术治疗。目前,对于非手术治疗的老年患者,很少有研究评估其预后因素。我们的目的是构建一个列线图,以预测非手术治疗的老年 PC 患者的癌症特异性生存(CSS),以评估其与预后相关的独立风险因素。患者信息来自监测、流行病学和最终结果(SEER)数据库,我们的目标人群是非手术治疗的年龄超过 65 岁的 PC 患者。使用单因素和多因素 Cox 回归模型确定独立风险因素。使用多因素 Cox 回归模型构建列线图。使用一致性指数(C 指数)、受试者工作特征曲线下面积(AUC)和校准曲线测试预测模型的准确性和区分度。决策曲线分析(DCA)用于检查该模型的潜在临床价值。共纳入 2010-2018 年 87831 例非手术治疗的老年 PC 患者,随机分为训练集(N=61595)和验证集(N=26236)。单因素和多因素 Cox 回归模型分析显示,年龄、种族、婚姻状况、TNM 分期、化疗、放疗方式、PSA 和 GS 是预测非手术治疗老年 PC 患者 CSS 的独立危险因素。训练集和验证集的 C 指数分别为 0.894(95%CI 0.888-0.900)和 0.897(95%CI 0.887-0.907),表明该列线图具有良好的区分能力。AUC 和校准曲线也显示出良好的准确性和区分能力。我们开发了一种新的列线图来预测非手术治疗的老年 PC 患者的 CSS。该模型具有良好的准确性和可靠性,内部验证结果良好,具有潜在的临床价值,可用于临床辅助决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/45d96ed7f661/41598_2023_44911_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/bcbf3657ec1e/41598_2023_44911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/da15f7418768/41598_2023_44911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/d6cd5e5369ae/41598_2023_44911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/bded29e70c8c/41598_2023_44911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/6c5768271058/41598_2023_44911_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/c385acc4e3a2/41598_2023_44911_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/a101008be9c9/41598_2023_44911_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/45d96ed7f661/41598_2023_44911_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/bcbf3657ec1e/41598_2023_44911_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/da15f7418768/41598_2023_44911_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/d6cd5e5369ae/41598_2023_44911_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/bded29e70c8c/41598_2023_44911_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/6c5768271058/41598_2023_44911_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/c385acc4e3a2/41598_2023_44911_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/a101008be9c9/41598_2023_44911_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d202/10584808/45d96ed7f661/41598_2023_44911_Fig8_HTML.jpg

相似文献

1
Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.制定并验证了一个列线图,用于预测未经手术治疗的老年前列腺癌患者的癌症特异性生存。
Sci Rep. 2023 Oct 18;13(1):17719. doi: 10.1038/s41598-023-44911-z.
2
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients Undergoing Surgery With Prostate Cancer: A Population-Based Study.基于网络的前列腺癌老年手术患者癌症特异性生存预测模型:基于人群的研究。
Front Public Health. 2022 Jul 12;10:935521. doi: 10.3389/fpubh.2022.935521. eCollection 2022.
3
Prognostic significance of surgery and radiotherapy in elderly patients with localized prostate cancer: establishing and time-based external validation a nomogram from SEER-based study.基于 SEER 研究的手术和放疗对局限性前列腺癌老年患者预后意义:建立和基于时间的外部验证nomogram。
BMC Urol. 2024 Jan 6;24(1):12. doi: 10.1186/s12894-023-01384-6.
4
Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.预测老年前列腺癌患者癌症特异性生存和总生存的列线图的开发与验证:一项基于人群的研究
Front Oncol. 2022 Jun 23;12:918780. doi: 10.3389/fonc.2022.918780. eCollection 2022.
5
Gleason score, surgical and distant metastasis are associated with cancer-specific survival and overall survival in middle aged high-risk prostate cancer: A population-based study.格里森评分、手术和远处转移与中年高危前列腺癌的癌症特异性生存和总生存相关:一项基于人群的研究。
Front Public Health. 2022 Oct 18;10:1028905. doi: 10.3389/fpubh.2022.1028905. eCollection 2022.
6
Nomogram for predicting outcomes in elderly women with mucinous breast cancer: A retrospective study combined with external validation in southwest China.预测中国西南部老年黏液性乳腺癌女性患者结局的列线图:一项回顾性研究并外部验证
Cancer Rep (Hoboken). 2024 Jul;7(7):e2112. doi: 10.1002/cnr2.2112.
7
Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study.开发和验证一种列线图,用于预测老年甲状腺乳头状癌患者的癌症特异性生存:一项基于人群的研究。
BMC Geriatr. 2022 Sep 8;22(1):736. doi: 10.1186/s12877-022-03430-8.
8
The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.基于 SEER 数据库的人群研究:用于预测老年早期肺癌患者总生存和癌症特异生存的列线图。
Front Public Health. 2022 Sep 8;10:946299. doi: 10.3389/fpubh.2022.946299. eCollection 2022.
9
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Hypopharyngeal Squamous Cell Carcinomas: A Population-Based Study.基于网络的老年下咽鳞癌患者癌症特异性生存预测模型:一项基于人群的研究。
Front Public Health. 2022 Jan 13;9:815631. doi: 10.3389/fpubh.2021.815631. eCollection 2021.
10
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.列线图预测Ⅰ期老年小细胞肺癌患者生存的建立与验证。
Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420.

引用本文的文献

1
Guided supportive care may benefit from predicting cancer treatment-induced toxicity-a methodology paper on utilization of nomograms to predict severe oral mucositis, Part I.指导性支持治疗可能会从预测癌症治疗引起的毒性中受益——关于利用列线图预测严重口腔黏膜炎的方法学论文,第一部分。
Support Care Cancer. 2025 Jul 1;33(7):651. doi: 10.1007/s00520-025-09691-4.
2
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy.接受[177Lu]Lu-DOTA-TATE治疗的胃肠胰神经内分泌肿瘤患者中综合生物标志物与无进展生存预测的关联
Theranostics. 2025 May 25;15(13):6444-6453. doi: 10.7150/thno.112588. eCollection 2025.
3

本文引用的文献

1
Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis.雄激素受体靶向药物联合雄激素剥夺治疗和多西他赛治疗转移性激素敏感前列腺癌的系统评价和荟萃分析。
ESMO Open. 2022 Oct;7(5):100575. doi: 10.1016/j.esmoop.2022.100575. Epub 2022 Sep 22.
2
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
3
Nomograms to predict outcomes after Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Limitations of nomogram models in predicting survival outcomes for glioma patients.
列线图模型在预测神经胶质瘤患者生存结局方面的局限性。
Front Immunol. 2025 Mar 18;16:1547506. doi: 10.3389/fimmu.2025.1547506. eCollection 2025.
4
Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis.80岁以上男性接受经直肠超声引导下前列腺穿刺活检的生存结果:一项前瞻性分析。
Cancers (Basel). 2024 Nov 28;16(23):3995. doi: 10.3390/cancers16233995.
5
External validation of a novel nomogram for diagnosis of Protein Energy Wasting in adult hemodialysis patients.一种用于诊断成年血液透析患者蛋白质能量消耗的新型列线图的外部验证
Front Nutr. 2024 Aug 13;11:1351503. doi: 10.3389/fnut.2024.1351503. eCollection 2024.
6
Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature.个体化检测前列腺癌中 TMPRSS2-ERG 融合状态:基于排名的定性转录组特征。
World J Surg Oncol. 2024 Feb 9;22(1):49. doi: 10.1186/s12957-024-03314-8.
Lu-PSMA 治疗转移性去势抵抗性前列腺癌患者预后的列线图:一项国际多中心回顾性研究。
Lancet Oncol. 2021 Aug;22(8):1115-1125. doi: 10.1016/S1470-2045(21)00274-6. Epub 2021 Jul 8.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial.局部前列腺癌外照射放疗中前列腺内肿瘤焦点增强:来自 FLAME 随机 III 期试验的结果。
J Clin Oncol. 2021 Mar 1;39(7):787-796. doi: 10.1200/JCO.20.02873. Epub 2021 Jan 20.
6
Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study.婚姻状况与伴远处转移膀胱癌的预后列线图:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Oncol. 2020 Oct 27;10:586458. doi: 10.3389/fonc.2020.586458. eCollection 2020.
7
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.根治性前列腺切除术后放疗时机(RADICALS-RT):一项随机对照 3 期试验。
Lancet. 2020 Oct 31;396(10260):1413-1421. doi: 10.1016/S0140-6736(20)31553-1. Epub 2020 Sep 28.
8
Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer.癌症和白血病协作组 B90203(Alliance):局限性高危前列腺癌的根治性前列腺切除术联合或不联合新辅助化疗-内分泌治疗。
J Clin Oncol. 2020 Sep 10;38(26):3042-3050. doi: 10.1200/JCO.20.00315. Epub 2020 Jul 24.
9
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.在前列腺癌 Gleason 评分 8 分的患者中,根治性前列腺切除术中的筛状结构可预测肿瘤学结局。
Mod Pathol. 2021 Jan;34(1):184-193. doi: 10.1038/s41379-020-0625-x. Epub 2020 Jul 20.
10
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.心血管风险和毒性 - 前列腺癌患者去势治疗的阿喀琉斯之踵。
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188383. doi: 10.1016/j.bbcan.2020.188383. Epub 2020 Jun 11.